The significance of enzyme and transporter polymorphisms for imatinib plasma levels and achieving an optimal response in chronic myeloid leukemia patients
oleh: Petra Belohlavkova, Filip Vrbacky, Jaroslava Voglova, Zdenek Racil, Daniela Zackova, Katerina Hrochova, Jana Malakova, Jiri Mayer, Pavel Zak
| Format: | Article |
|---|---|
| Diterbitkan: | Termedia Publishing House 2018-02-01 |
Deskripsi
Subjek
clinical response; imatinib; chronic myeloid leukemia; genetic polymorphisms